text:
User talk:2die4~enwikibooks

Welcome message
G'day, I note that you have an interest in fermentation. So do I! What was your intention with the nuts and seeds?

Here's our bulk / cookie-cutter welcome:

Come introduce yourself at the new users page. If you have any questions, you can ask there or contact me personally.

You might also be interested to read our Cookbook policy page and talk to other Cookbook editors. Webaware talk 16:36, 19 September 2007 (UTC)

Your account will be renamed
Hello,

The developer team at Wikimedia is making some changes to how accounts work, as part of our on-going efforts to provide new and better tools for our users like cross-wiki notifications. These changes will mean you have the same account name everywhere. This will let us give you new features that will help you edit and discuss better, and allow more flexible user permissions for tools. One of the side-effects of this is that user accounts will now have to be unique across all 900 Wikimedia wikis. See the announcement for more information.

Unfortunately, your account clashes with another account also called 2die4. To make sure that both of you can use all Wikimedia projects in future, we have reserved the name 2die4~enwikibooks that only you will have. If you like it, you don't have to do anything. If you do not like it, you can pick out a different name.

Your account will still work as before, and you will be credited for all your edits made so far, but you will have to use the new account name when you log in.

Sorry for the inconvenience.

Yours, Keegan Peterzell Community Liaison, Wikimedia Foundation 22:54, 17 March 2015 (UTC)

Renamed
 This account has been renamed as part of single-user login finalisation. If you own this account you can |log in using your previous username and password for more information. If you do not like this account's new name, you can choose your own using this form after logging in: . -- Keegan (WMF) (talk) 04:27, 19 April 2015 (UTC)

title: User talk:2die4~enwikibooks


text:
Muggles' Guide to Harry Potter/Characters/Kendra Dumbledore

Overview
Kendra Dumbledore was the mother of Albus, Aberforth, and Ariana Dumbledore, and wife of Percival Dumbledore.

Deathly Hallows
Kendra Dumbledore, Albus Dumbledore's mother, is mentioned in Albus' obituary written by Elphias Doge. She had died suddenly as Albus was preparing for a Grand Tour around the world following his graduation from Hogwarts.

In Rita Skeeter's scurrilous tell-all book, Kendra is described as having been extremely private, rebuffing her neighbours' offers of friendship following the Dumbledore clan's move to Godric's Hollow. Kendra was rumored to be hiding a shameful family secret: that her daughter, Ariana, was a Squib. Ron's Auntie Muriel later confirms the rumors existed, though they were unproven.

Harry learns later from Albus' brother, Aberforth, that Ariana was beaten by Muggles and suffered permanent brain damage. Their father, Percival, physically retaliated against the three boys, then was convicted and sentenced to Azkaban prison, where he later died. Kendra relocated the family to Godric's Hollow to escape the notoriety. Ariana never fully recovered from the attack, and had uncontrollable magical outbursts. Kendra kept her hidden to protect the neighbours and to prevent Ariana from being forcefully committed to St. Mungo's. Ariana may have killed Kendra during an uncontrolled fit.

license: Creative Commons - Attribution Share-Alike - https://creativecommons.org/licenses/by-sa/4.0/


text:
Muggles' Guide to Harry Potter/Characters/Percival Dumbledore

Overview
Percival Dumbledore was the father of Albus, Aberforth, and Ariana Dumbledore, and husband of Kendra Dumbledore.

Deathly Hallows
Little is known about Percival. In Elphias Doge's obituary of Albus Dumbledore, it is mentioned that Percival had been sentenced to Azkaban Prison, and later died there. In Rita Skeeter's tell-all book published following Albus' death, we learn that Percival was convicted for attacking three Muggle boys. Harry later learns from Aberforth Dumbledore, Albus' brother, that the three Muggles had previously assaulted and permanently brain-damaged Percival's young daughter, Ariana.


text:
Muggles' Guide to Harry Potter/Characters/Auntie Muriel

Overview
Ron's Auntie Muriel (no mention whether she's a Weasley or a Prewett, though her opinions suggest she is a Prewett) is an aged, outspoken, eccentric relative of the Weasley family.

Half-Blood Prince
Fleur Delacour and Bill Weasley are engaged, but Bill has just received dreadful wounds from Fenrir Greyback that are unlikely to ever heal. Molly Weasley, tending his injuries, laments that the wedding is now not going to happen. Fleur, outraged, says that the wedding most certainly is going to happen, and pushes Molly aside to take over tending Bill's wounds. Briefly stunned, Molly tells Fleur that Auntie Muriel has a goblin-made tiara that would look good in Fleur's hair, and says she'll see if she can convince Muriel to loan it to her. Fleur accepts. This marks the reconciliation between the two women.

Deathly Hallows
As the seven Harry Potters escape from Privet Drive, each Potter and protector pair is destined for a different safe house. Ron and Tonks are destined for Auntie Muriel's. Muriel keeps them busy for so long after they arrive that they miss their Portkey, and there is a great deal of worry at the Weasley house until they finally arrive on Tonks' broom.

Auntie Muriel is one of the wedding guests, who expects preferential treatment because, "I'm a hundred and seven." She arrives on Ron's arm, criticizing the length of his hair – she claims that for a moment she had mistaken him for Ginevra. She briefly accuses Ron of lying about knowing Harry Potter when Ron says he has made his excuses – Harry is present, but in disguise. Ron takes her, still grumbling, to her seat, where she evidently keeps him occupied for some time.

After the ceremony, during the music afterwards, Harry is speaking with Elphias Doge about the eulogy he had written for Albus Dumbledore, and the muck-raking book that Rita Skeeter had written on the same subject. Auntie Muriel, passing by, hears the conversation and joins it, saying that she couldn't wait to read Skeeter's book, she reads everything she writes. She goes on to say that she believes that Dumbledore had practiced Dark magic as a youth, and that his sister Ariana was most likely a Squib. She claims that Ariana had been locked up, as it was taken to be a disgrace to have produced a Squib, and so it was common practice in those days to try to hide the child, integrating him or her with Muggles. In response to Elphias' protests, she says that Ariana couldn't have been sickly, because her cousin Launcelot was a healer at St. Mungo's, and Ariana had never been there. She goes on to say that she believes that Rita's source was Bathilda Bagshot, and that she was likely still alive, and still living in Godric's Hollow, where the Dumbledores had lived as well. Harry, taken quite by surprise by this last revelation, wonders why Professor Dumbledore had never told him of this connection.

Auntie Muriel's stream of revelations is broken by the announcement that the Ministry has fallen and Rufus Scrimgeour has been killed. This effectively ends the wedding party, and Harry, Hermione, and Ron depart.

Much later, when Harry, Ron, and Hermione are recovering at Shell Cottage, they learn that several of the Weasley clan are now living in Aunt Muriel's house. Apparently, Fred and George are attempting to run Weasleys' Wizard Wheezes by mail order out of one of her back bedrooms. When Ollivander is taken to her house by Bill Weasley, Fleur asks him to carry the tiara that she had worn at the wedding back to Auntie Muriel.

Relationships with Other Characters
Auntie Muriel is an incurable gossip, in some ways as bad as Rita Skeeter, of whom she is a great fan. She never hesitates to make use of her age to claim preferential treatment. She disapproves of Hermione, and has said that Weasleys breed like gnomes.

It is also stated by Ginny that Ron keeps a picture of Aunt Muriel under his pillow, who he kisses before he goes to sleep each night. However, this was said during a fight, and is most likely untrue.


text:
Muggles' Guide to Harry Potter/Characters/Bathilda Bagshot

Overview
Bathilda Bagshot, author of A History of Magic, one of the textbooks in use throughout Harry's school career, lives in Godric's Hollow.

Philosopher's Stone
One of the books that Harry must purchase in Diagon Alley is A History of Magic by Bathilda Bagshot.

Prisoner of Azkaban
The book A History of Magic is mentioned early in the book as Harry has to do homework over the summer and is using this book as reference. Note that some editions of Harry Potter and the Prisoner of Azkaban mistakenly list this book as being written by Adalbert Waffling.

Deathly Hallows
At Fleur and Bill's wedding, Harry speaks with Elphias Doge and Ron's Auntie Muriel. There, he learns that the source used by Rita Skeeter for her scurrilous book about Albus Dumbledore was most likely Bathilda Bagshot, who is apparently living in Godric's Hollow, where Harry's parents had lived, and to Harry's surprise, where the Dumbledore family had lived. This cements Harry's intention to go to Godric's Hollow.

It is mentioned that Bathilda at the time was very nearly senile, and that Rita Skeeter had used Veritaserum to get the recollections of Dumbledore's early life from her.

On arriving at Godric's Hollow near Christmas of that year, Harry and Hermione are surprised to find that a resident of the village can apparently perceive them, despite their being under the Invisibility Cloak. The resident responds positively when asked if she is Bathilda Bagshot; she takes them to her house, which is an absolute mess, and Harry notes a strange odor, as of rotten meat. Taking Harry upstairs, Bathilda collapses and a large snake, Nagini, leaves her body and starts attacking Harry. Hermione comes to the rescue, and the two of them Disapparate under Voldemort's nose.

Later, Harry hears that Bathilda has been found dead, and Dark magic involvement is suspected.

Strengths
Bathilda wrote the definitive textbook on the History of Magic, so clearly her understanding of history must have been exceptionally good. Whether she had access to special magic to aid her historical research is unknown, as we never see any such, but it seems somehow likely.

Weaknesses
By the time we first hear of her, Bathilda is extremely old, and we can expect that apart from the senility that Rita Skeeter mentions, other age-related weakness will have eliminated almost all of her strength, magical and otherwise.

Relationships with Other Characters
In the letter which Lily Potter writes to Sirius Black, and which Harry sees in Grimmauld Place when he searches Sirius' room, Lily mentions that Bathilda seems friendly. Rita Skeeter's book quotes Bathilda as saying that she had tried to be friends with the Dumbledore family but had been rebuffed. One gets the impression that Bathilda is an outgoing person, perhaps one who likes to be the center of a gossip circle.

Analysis
We never meet Bathilda Bagshot in person; by the time we actually see her, in Harry Potter and the Deathly Hallows, she is apparently a dead body, animated sketchily either by the presence of Nagini within her, or by the same magic that creates and preserves Inferi. Harry detects the odor of spoiled meat in her house, and we come to understand that this is Bathilda herself. There is no indication of how long she has been dead, but it is likely that it has been some time, as it seems that her author's copy of Rita Skeeter's book, presumably sent in August or September, has not been touched. It is possible that Voldemort had set this trap as long as some five months before. We see that Nagini is with him in the first chapter of the book, which occurs in late July. This suggests that Bathilda had died sometime after July, and quite possibly at Voldemort's hand, after which Nagini would have been living within her remains. While the fact that Bathilda's copy of Skeeter's book had been set on the mantel, rather than being left sitting on the doormat, this does not really give us any certainty as to the time of her death. The book having been set on the mantel argues that it was placed there by Bathilda, and then forgotten, putting her death after the August or September release date. It is also possible that Nagini might have moved the book in order to remain inconspicuous, though it seems unlikely that Nagini would have carefully placed it on the mantel, instead just pushing it into an inconspicuous corner. And of course, it is possible that the delivery owl, not finding Bathilda at home, might have dropped the book on the mantel; we have seen, as early as the first book, that delivery owls will enter structures to make deliveries. It is perhaps suggestive, though certainly inconclusive, that we do not see Nagini after the first chapter, until Harry triggers the trap late Christmas Eve or early Christmas morning.

Questions

 * 1) The author has said that Albus Dumbledore was born in 1881, and apparently died in 1997 at age 115 or 116. Remembering that Bathilda Bagshot was already mature enough to be host for Gellert Grindelwald when he and Dumbledore were about 17, how old must Bathilda have been at her death in 1997?
 * 2) Bathilda shouts "Come!" during Deathly Hallows, which both Harry and Hermione seem to be able to understand. Is this Dark magic animating her speech, or Nagini speaking Parseltongue?


text: Wikibooks:Requests for deletion/Image:Wikibooks German-English Film Glossary.pdf


text: Wikibooks:Requests for deletion/Geospatial Topology


text:
Radiation Oncology/Endometrium/UPSC

Uterine Papillary Serous Carcinoma

Overview

 * ''Please also see Endometrium Overview page
 * First identified at Stanford in 1982, where it comprised ~10% of Stage I endometrial CA but resulted in 50% of relapses. Many relapses were characterized by upper abdominal failure
 * 5-year disease-specific survival is worse for USC compared with grade 3 endometrioid carcinoma
 * Stage I USC 72% vs ECCG3 76% (NS)
 * Stage I/II USC 74% vs ECCG3 85% (SS)
 * Stage III/IV USC 33% vs ECCG3 54% (SS)
 * Due to similar behavior as ovarian carcinoma, adjuvant abdominal radiation was proposed. *GOG started a trial in 1986 (GOG 94) to evaluate treatment of advanced endometrial cancer with whole abdominal RT (WART), pelvic RT, and para-aortic boost as necessary. Eligible patients included Stage I-II UPSC and CC. Over 50% of failures for UPSC/CC patients were within the radiation field. WART alone is not sufficient

Pathology

 * Endometrioid (75-80%)
 * Clear cell (5-10%)
 * Clear due to presence of glycogen
 * Tubulocystic, papillary, or solid patterns
 * Psammoma bodies not as common
 * Have to be present in at least 25-50% (depending on pathologist) of sample to qualify as clear cell
 * Aggressive, with myometrial invasion in ~80%
 * Papillary serous (1-5%)
 * Complex papillary architecture, similar to papillary serous CA of ovary
 * Presence of psammoma bodies
 * Marked nuclear atypia
 * Believed to transform from endometrial surface epithelium
 * Mixed pattern
 * Serous and endometrioid histology present next to each other in the specimen
 * If >50% serous component, classified as papillary serous
 * If 10-50% serous component, classified as mixed serous
 * Rare tumor types (<2%)
 * Mucinous, squamous cell, transitional cell, small cell

Pathology

 * Stanford; 1982 PMID 7102898 -- "Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma." (Hendrickson M, Am J Surg Pathol. 1982 Mar;6(2):93-108.)
 * Retrospective. 256 Stage I uterine adenoCA reviewed, 26 UPSC identified. High cytologic anaplasia and papillary growth pattern. Frequent LVI+, frequent Stage IC (40% vs. 12%)
 * Outcome: relapse rate ~50% vs. 5%; Stage IC relapse 63% vs. 30%. Tendency to relapse over peritoneal surfaces
 * Conclusion: Clinically aggressive, similar to ovarian CA

Sentinel Node Staging

 * Memorial Sloan Kettering; 2017 (2005 - 2015) PMID 28258415 -- "Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping." (Schiavone MB, Ann Surg Oncol. 2017 Jul;24(7):1965-1971. doi: 10.1245/s10434-017-5816-4. Epub 2017 Mar 3.)
 * Retrospective. 248 patients (153 SLN and 95 LND). Stage distribution comparable (I-II in 69% vs 62%, III in 31% vs 38%). Median LN removed 12 vs 21 (SS). Adjuvant chemo or chemo-RT comparable (80% vs 83%), adjuvant RT alone comparable (8% vs 7%). Median F/U 3.3 years
 * Outcome: 2-year PFS SLN 77% vs LND 71% (NS)
 * Conclusion: Incorporating SLN into staging of uterine serous cancer does not appear to compromise prognosis

Stage I

 * Mayo; 2007 (1982-2005) PMID 17688926 -- "Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma." (Thomas MB, Gynecol Oncol. 2007 Aug 2; [Epub ahead of print])
 * Retrospective. 42 patients (IA 15, IB 21, IC 6). 81% LND, 69% omentectomy, 45% peritoneal biopsies. Median F/U 3.2 years
 * Outcome: 5-year OS 85%, PFS 78%. By stage OS IA 100%, IB 89%, IC 60%.
 * Recurences: LN recurrence in LND 0/34 vs. no LND 1/8 (NS); none in IA regardless of post-op therapy; 0/20 IB and IC who had vaginal BT vs. 2/7 with no vaginal BT (SS). Hematogenous/peritoneal recurrence in 0/6 patients with chemo vs. 3/13 patients with no chemo.
 * Conclusion: Observation reasonable for IA if LND done; for IB and IC consider chemotherapy and vaginal brachytherapy

 * Yale; 1998 PMID 9422561 -- "Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy." (Turner BC, Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):77-84.)
 * Retrospective. 38 patients treated with TAH/BSO, +/-LND, with combinations of chemo and RT. 20 patients vaginal LDR with WART or WPRT (6/20 had complete surgical staging, 2/20 concurrent chemo). 18 patients vaginal HDR (15/18 had complete surgical staging, 5/18 concurrent chemo).
 * Outcome: 5-year OS complete surgical staging and HDR /chemo 100% vs. incomplete staging HDR/chemo 61% vs. complete staging LDR/WART 100% vs. incomplete staging LDR/WART 65%. OS by stage IA 100%, Stage IB 71%, Stage IC 40%
 * Toxicity: WART and/or LDR had Grade 3-4 toxicity in 15%, complications from vaginal HDR minimal
 * Conclusion: If complete surgical staging, can be effectively and safely treated with vaginal HDR and chemotherapy

General

 * Harvard; 2011 (1980-2006) PMID 21963091 -- "The importance of chemotherapy and radiation in uterine papillary serous carcinoma." (Viswanathan AN, Gynecol Oncol. 2011 Dec;123(3):542-7. doi: 10.1016/j.ygyno.2011.09.005. Epub 2011 Oct 2.)
 * Retrospective. 135 women, Stage I-IVA UPSC. Stage I 47%, Stage II 12%, Stage III 37%, Stage IVA 4%. Chemotherapy in 32%. Radiation in 66% (whole abdomen 24%, pelvis 31%, brachytherapy 33%). Mean F/U 5.5 years.
 * Outcome: Median 5-year OS 52%, RFS 42%. OS improved by paclitaxel-containing chemotherapy (HR 0.34, SS). RFS improved by radiation (HR 0.44, SS). 5-year LR 15%, reduced by RT (HR 0.2). 5-year DM 26%, not reduced by paclitaxel/carboplatin
 * Stage IA outcome: N=21. 5-year OS 71%. No further therapy N=17, pelvic RT N=4. Relapse in 5 patients (24%), vaginal 1, vaginal/pelvic 1, lymphatic 1, peritoneal 1, distant 1.
 * Toxicity: Grade 3+ in 3.5% with RT, 2.9% without RT (NS)
 * Conclusion: RFS was improved by radiation and chemotherapy, and should be attempted whenever feasible

"Sandwich" chemotherapy and radiation

 * Albert Einstein College of Medicine; 2012 PMID 22035806 -- "Phase II trial of adjuvant pelvic radiation "sandwiched" between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma." (Einstein MH, Gynecol Oncol. 2012 Jan;124(1):21-5. Epub 2011 Oct 27.)
 * Phase II. 81 patients (89% completed chemo->RT and are reported here), surgically staged UPSC, no visible residual. Stage I/II 82%, Stage III/IV 18%. Adjuvant paclitaxel 175 mg/m2 and carboplatin AUC 6 Q3 weeks x 3 cycles, followed by RT (pelvis 45/25, PA if 2+ pelvic nodes or documented PA disease, HDR vaginal brachytherapy 5 Gy x 3 at 0.5 cm), followed by chemotherapy x 3 cycles. Protocol completion 83%
 * Outcome: Stage I/II OS 6.3 years, Stage III/IV OS 3.0 years. 3-year OS 84% and 50%. PFS 5.4 years and 2.1 years
 * Toxicity: G3/4 non-hematologic toxicity 2.5%
 * Conclusion: RT-chemotherapy "sandwich" is well and highly efficacious in completely resected UPSC

Patterns of Failure

 * Westmead Hospital, Sydney, Australia; 2009 (1995-2006) PMID 19694700 -- "Uterine papillary serous carcinoma: patterns of failure and survival." (Wang W, Aust N Z J Obstet Gynaecol. 2009 Aug;49(4):419-25.)
 * Retrospective. ? patients, TAH/BSO/surgical staging, majority with platinum-based chemotherapy and radiotherapy
 * Outcome: 2-year OS 65%, 5-year OS 43%. Macroscopic residual disease only predictor of survival (if R2, median OS 11 months). Site of recurrence vagina (n=5; for VBT 1/16 recurrences, for EBRT 4/7 recurrences), pelvic LN (n=24), para-aortic LN (n=6), inguinal LN (n=2), abdomen (n=11), and distant mets (n=7)
 * Conclusion: Recommend optimal cytoreduction; vaginal brachytherapy should be considered as a component of adjuvant radiotherapy. Abdominal failure most common

Whole Abdomen RT

 * GOG 94 (1986-1994)
 * 2006 PMID 16213007 -- "Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group." (Sutton G, Gynecol Oncol. 2006 Feb;100(2):349-54.)
 * Phase II. 21 patients treated with TAH/BSO, PPALND, WART 30/20 and pelvic boost to 50 Gy
 * Outcome: >50% failures within RT field
 * UPSC: 5-year OS 38%, PFS 38%
 * Clear cell: 5-year OS 54%, PFS 54%
 * Toxicity: 17% Grade 3-4 GI toxicity (SBO, proctitis, N/V)
 * Conclusion: WART alone not adequate, chemotherapy needs to be a component of treatment. Clear cell better outcome than UPSC

 * Stanford; 2000 (1979-1998) PMID 11020574 -- "Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy." (Smith RS, Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):767-78.)
 * Retrospective. 48 patients with Stage III-IV endometrial ACA (n=22) or Stage I-IV UPSC or CC (n=26), treated with postop WART. Median dose 30 Gy abdomen (in 1.2-1.5 Gy/fx) and 50 Gy pelvis (in 1.2-1.8 Gy/fx). PALN boost to 44 Gy in 9 patients. Vaginal brachy in 24 patients. Mean F/U 3.1 years
 * Outcome: 3-year OS all patients 77%, ACA 89% vs. UPSC/CC 68%; UPSC/CC Stage I-II OS 87% vs. Stage III-IV 61%; DFS 87% vs. 31%
 * Toxicity: major complications (SBO) 7%, no deaths, 23% required break >1 week
 * Conclusion: WART is safe, effective. Recommend with vaginal cuff brachy for Stage I-II. Recommend with concurrent or sequential chemo in Stage III-IV UPSC/CC until results of GOG 94 and GOG 122 become available (see Advanced Stage chapter).

Phosphorus-32 (P32)

 * HOG 97-01 PMID 15721431 -- "Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study." (Fakiris AJ, Gynecol Oncol. 2005 Mar;96(3):818-23.)
 * Phase II. 21 patients s/p TAH-BSO, residual peritoneal disease <3mm, negative PPALN. Intraperitoneal P-32 15 mCi within 8 weeks. Vaginal BT. Median F/U
 * Outcome: 2-year OS 89%, DFS 80%; recurrences 5/21, but only 2/21 intraperitoneal
 * Toxicity: No Grade 2-4
 * Conclusion: Adjuvant intraperitoneal P-32 and vaginal BT feasible, well tolerated

Reviews

 * 2009: SGO PMID 19592079 PDF -- "Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review." (Boruta DM, Gynecol Oncol. 2009 Oct;115(1):142-53.)

title: Radiation Oncology/Endometrium/UPSC


text:
User talk:208.67.117.50

Thanks for experimenting with Wikibooks. Your test worked, and has now been removed. Please use Sandbox for any other tests you want to do, since testing material in modules will normally be removed quickly. Please see the welcome page if you would like to learn more about contributing to our project. Thanks.– Mike.lifeguard  | talk 19:05, 19 September 2007 (UTC)

title: User talk:208.67.117.50


text:
User talk:Cory37c

Come introduce yourself at the new users page. If you have any questions, you can ask there or contact me personally.– Mike.lifeguard  | talk 19:08, 19 September 2007 (UTC)

title: User talk:Cory37c


text:
User talk:165.139.0.20

Thanks for experimenting with Wikibooks. Your test worked, and has now been removed. Please use Sandbox for any other tests you want to do, since testing material in modules will normally be removed quickly. Please see the welcome page if you would like to learn more about contributing to our project. Thanks.– Mike.lifeguard  | talk 19:09, 19 September 2007 (UTC)

title: User talk:165.139.0.20


text:
User talk:67.182.19.216

Thanks for experimenting with Wikibooks. Your test worked, and has now been removed. Please use Sandbox for any other tests you want to do, since testing material in modules will normally be removed quickly. Please see the welcome page if you would like to learn more about contributing to our project. Thanks.– Mike.lifeguard  | talk 19:10, 19 September 2007 (UTC)

title: User talk:67.182.19.216


text:
User talk:38.97.64.145

– Mike.lifeguard  | talk 19:11, 19 September 2007 (UTC)

title: User talk:38.97.64.145


text:
User talk:80.229.150.166

Thanks for reverting vandalism! – Mike.lifeguard  | talk 19:12, 19 September 2007 (UTC)

title: User talk:80.229.150.166


text:
User talk:86.139.178.49

– Mike.lifeguard  | talk 19:12, 19 September 2007 (UTC)

title: User talk:86.139.178.49


text:
Java Persistence/Runtime

Once you have mapped your object model the second step in persistence development is to access and process your objects from your application, this is referred to as the runtime usage of persistence. Various persistence specifications have had various runtime models. The most common model is to have a runtime API; a runtime API typically will define API for connecting to a data-source, querying and transactions.

=Entity Manager= JPA provides a runtime API defined by the  package. The main runtime class is the  class. The EntityManager provides API for creating queries, accessing transactions, and finding, persisting, merging and deleting objects. The JPA API can be used in any Java environment including JSE and JEE.

An EntityManager can be created through an, or can be injected into an instance variable in an EJB SessionBean, or can be looked up in JNDI in a JEE server.

JPA is used differently in Java Standard Edition (JSE) versus Java Enterprise Edition (JEE).

Java Standard Edition
In Java SE an  is accessed from the JPA  class through the   API. The persistent unit name is passed to the, this is the name given in the persistence unit's   file. All Java SE JPA applications must define a  file. The file defines the persistence unit including the name, classes, orm files, datasource, vendor specific properties.

JPA 1.0 does not define a standard way of specifying how to connect to the database in Java SE. Each JPA provider defines their own persistence properties for setting the JDBC driver manager class, URL, user and password. JPA has a standard way of setting the  JNDI name, but this is mainly used in JEE.

JPA 2.0 does define standard persistence unit properties for connecting to JDBC in Java SE. These include,,  ,  ,.

The JPA application is typically required to be packaged into a persistence unit jar file. This is a normal jar, that has the  file in the   directory. Typically a JPA provider will require something special be done in Java SE to enable certain features such as lazy fetching, such as static weaving (byte-code processing) of the jar, or using a Java agent JVM option.

In Java SE the  must be closed when your application is done with it. The life-cycle of the  is typically per client, or per request. The  can be shared among multiple threads or users, but the   should not be shared.

Java Enterprise Edition
In Java EE the  or   can either be looked up in JNDI, or injected into a. To look up the  in JNDI it must be published in JNDI such as through a   in a  's   file. To inject an  or   the annotation   or   are used.

In Java EE an  can either be managed (container-managed) or non-managed (application-managed). A managed  has a different life-cycle than an   managed by the application. A managed  should never be closed, and integrates with JTA transactions so local transaction cannot be used. Across each JTA transaction boundary all of the entities read or persisted through a managed  become detached. Outside of a JTA transaction a managed 's behavior is sometimes odd, so typically should be used inside a JTA transaction.

A non-managed  is one that is created by the application through a   or directly from. A non-managed  must be closed, and typically does not integrate with JTA, but this is possible through the   API. The entities in a non-managed  do not become detached after a transaction completes, and can continue to be used in subsequent transactions.

Example of lookup an EJBContext in an Entity
(Useful for Audit)

Stateful SessionBeans
/Runtime

title: Java Persistence/Runtime


text:
User talk:Arjen Dijksman

Welcome message
Hello, and welcome to Wikibooks!

Here are some tips to help you get started:
 * To learn the wiki-markup-language syntax, see Help:Editing.
 * You should sign your name on Talk and vote pages using four tildes, like this: ~~~~
 * There is a box at the top of the edit window that will insert this, too; it looks like part of a signature.
 * Remember to conduct any editing experiments in the sandbox.
 * You can tell the community something about yourself in your userpage.
 * You can get to this page by clicking the tab at the top of the page labeled with your registered username.
 * If you are a Wikipedian, see Wikibooks for Wikipedians for a primer on how things work here (it's a little different).
 * If you want to base your work here on materials from Wikipedia, please use WB:RFI (requests for importation) to bring the material over in compliance with the GFDL.
 * If you're an instructor and plan on using Wikibooks for a class project, see Guidelines for class projects
 * Please say hello at the Staff Lounge with any questions or ideas.
 * Eventually, you might want to read the Manual of Style and Policies and Guidelines.
 * Please take a look at Naming policy before starting a new book.
 * Remember to maintain a Neutral point of view.
 * Explore, be bold in editing pages, and have fun!

You will find more resources in Community Portal. If you want to ask a question, visit the Study help desk, the Staff lounge, IRC channel or ask me personally on my talk page. For site news, see the Bulletin board. It might be a good idea to add this page to your "watchlist" so that you can see when any new information is posted there. You can do that by clicking the tab labeled "watch" at the top of the page.

Good luck! --Panic 19:28, 19 September 2007 (UTC)

title: User talk:Arjen Dijksman


text:
User talk:Chridd

Welcome message
Hello, and welcome to Wikibooks!

Here are some tips to help you get started:
 * To learn the wiki-markup-language syntax, see Help:Editing.
 * You should sign your name on Talk and vote pages using four tildes, like this: ~~~~
 * There is a box at the top of the edit window that will insert this, too; it looks like part of a signature.
 * Remember to conduct any editing experiments in the sandbox.
 * You can tell the community something about yourself in your userpage.
 * You can get to this page by clicking the tab at the top of the page labeled with your registered username.
 * If you are a Wikipedian, see Wikibooks for Wikipedians for a primer on how things work here (it's a little different).
 * If you want to base your work here on materials from Wikipedia, please use WB:RFI (requests for importation) to bring the material over in compliance with the GFDL.
 * If you're an instructor and plan on using Wikibooks for a class project, see Guidelines for class projects
 * Please say hello at the Staff Lounge with any questions or ideas.
 * Eventually, you might want to read the Manual of Style and Policies and Guidelines.
 * Please take a look at Naming policy before starting a new book.
 * Remember to maintain a Neutral point of view.
 * Explore, be bold in editing pages, and have fun!

You will find more resources in Community Portal. If you want to ask a question, visit the Study help desk, the Staff lounge, IRC channel or ask me personally on my talk page. For site news, see the Bulletin board. It might be a good idea to add this page to your "watchlist" so that you can see when any new information is posted there. You can do that by clicking the tab labeled "watch" at the top of the page.

Good luck! --Panic 19:28, 19 September 2007 (UTC)

title: User talk:Chridd


text:
User talk:CommonsDelinker

This is a bot operated by meta:User:Siebrand and it can't read. Questions on the bot and its behaviour should be raised with the maintainer here.

If the bot is misbehaving on Wikibooks, please request assistance in the Reading Room.

title: User talk:CommonsDelinker


text:
User talk:Aelli026

Welcome message
Hello, and welcome to Wikibooks!

Here are some tips to help you get started:
 * To learn the wiki-markup-language syntax, see Help:Editing.
 * You should sign your name on Talk and vote pages using four tildes, like this: ~~~~
 * There is a box at the top of the edit window that will insert this, too; it looks like part of a signature.
 * Remember to conduct any editing experiments in the sandbox.
 * You can tell the community something about yourself in your userpage.
 * You can get to this page by clicking the tab at the top of the page labeled with your registered username.
 * If you are a Wikipedian, see Wikibooks for Wikipedians for a primer on how things work here (it's a little different).
 * If you want to base your work here on materials from Wikipedia, please use WB:RFI (requests for importation) to bring the material over in compliance with the GFDL.
 * If you're an instructor and plan on using Wikibooks for a class project, see Guidelines for class projects
 * Please say hello at the Staff Lounge with any questions or ideas.
 * Eventually, you might want to read the Manual of Style and Policies and Guidelines.
 * Please take a look at Naming policy before starting a new book.
 * Remember to maintain a Neutral point of view.
 * Explore, be bold in editing pages, and have fun!

You will find more resources in Community Portal. If you want to ask a question, visit the Study help desk, the Staff lounge, IRC channel or ask me personally on my talk page. For site news, see the Bulletin board. It might be a good idea to add this page to your "watchlist" so that you can see when any new information is posted there. You can do that by clicking the tab labeled "watch" at the top of the page.

Good luck! --Panic 19:35, 19 September 2007 (UTC)

title: User talk:Aelli026


text:
User talk:Etayl018

Welcome message
Hello, and welcome to Wikibooks!

Here are some tips to help you get started:
 * To learn the wiki-markup-language syntax, see Help:Editing.
 * You should sign your name on Talk and vote pages using four tildes, like this: ~~~~
 * There is a box at the top of the edit window that will insert this, too; it looks like part of a signature.
 * Remember to conduct any editing experiments in the sandbox.
 * You can tell the community something about yourself in your userpage.
 * You can get to this page by clicking the tab at the top of the page labeled with your registered username.
 * If you are a Wikipedian, see Wikibooks for Wikipedians for a primer on how things work here (it's a little different).
 * If you want to base your work here on materials from Wikipedia, please use WB:RFI (requests for importation) to bring the material over in compliance with the GFDL.
 * If you're an instructor and plan on using Wikibooks for a class project, see Guidelines for class projects
 * Please say hello at the Staff Lounge with any questions or ideas.
 * Eventually, you might want to read the Manual of Style and Policies and Guidelines.
 * Please take a look at Naming policy before starting a new book.
 * Remember to maintain a Neutral point of view.
 * Explore, be bold in editing pages, and have fun!

You will find more resources in Community Portal. If you want to ask a question, visit the Study help desk, the Staff lounge, IRC channel or ask me personally on my talk page. For site news, see the Bulletin board. It might be a good idea to add this page to your "watchlist" so that you can see when any new information is posted there. You can do that by clicking the tab labeled "watch" at the top of the page.

Good luck! --Panic 19:35, 19 September 2007 (UTC)

title: User talk:Etayl018


text: Template:Goodbook/Non-Programmer's Tutorial for Python 2.6